Investment Summary

Five Arrows Invests In Averhealth

On July 1, 2019, private equity firm Five Arrows invested in healthcare services company Averhealth

Investment Highlights
  • This is Five Arrows’ 6th transaction in the Healthcare Services sector.
  • This is Five Arrows’ 4th transaction in the United States.
  • This is Five Arrows’ 1st transaction in Virginia.

Investment Summary

Date 2019-07-01
Target Averhealth
Sector Healthcare Services
Investor(s) Five Arrows
Deal Type Growth Capital

Target

Averhealth

Richmond, Virginia, United States
website
Avertest is specialized in providing substance use monitoring services tailored to the unique needs of judicial programs that operate at the holistic intersection of justice-involved and behavioral health. Avertest was founded in 1995 and is based in Richmond, Virginia.

Search 192,907 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Five Arrows

Paris, France

Investor Investor Investor Investor Investor

website


Category Private Equity Firm
PE ASSETS 24.0B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

Five Arrows Principal Investments is a mid-cap investor in Western European companies. Five Arrows can invest across the capital structure (equity, equity-linked, mezzanine, convertible debt) and generally focused on primary or secondary buyouts, growth financings, and balance sheet restructurings. The Group does not have any sector preferences, but typically looks for businesses with high barriers to entry and predictable earnings. Five Arrows can commit €30 to €400 million per investment. Five Arrows is a unit of Rothschild Bank. The Group has offices in Paris, Luxembourg, and London.


DEAL STATS #
Overall 32 of 52
Sector (Healthcare Services) 6 of 6
Type (Growth Capital) 4 of 6
State (Virginia) 1 of 1
Country (United States) 4 of 9
Year (2019) 3 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-05-01 RH Diagnostik und Therapie

Munich, Germany

RH Diagnostik und Therapie is an outpatient radiology platform operating diagnostic and therapy centres across Germany. Additionally, the business operates a senology hospital in Dusseldorf. The group is focused on diagnostic imaging (including MRI, CT, X-Ray and mammography screening), radiotherapy and nuclear medicine, which it provides through its own network of outpatient centres as well as through partner hospitals. RH Diagnostik und Therapie was founded in 2015 and is based in Munich, Germany.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-10-08 Solifi

Minneapolis, Minnesota, United States

Solifi streamlines the entire asset finance process from origination, to portfolio management, to end-of term. The company's cloud-based offerings integrate seamlessly into any asset finance ecosystem, offering unparalleled scalability, flexibility and economy to banks, independents and captives of all sizes. Headquartered in Minneapolis, MN, IDS also has offices in the United Kingdom, Australia, Singapore and India. Solifi was founded in 1974 and is based in Minneapolis, Minnesota.

Buy -